National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings, 22166 [2024-06698]
Download as PDF
<![CDATA[
22166
Federal Register / Vol. 89, No. 62 / Friday, March 29, 2024 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
The meetings will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), title 5 U.S.C., as amended for
the review, discussion, and evaluation
of individual intramural programs and
projects conducted by the National
Institute of Neurological Disorders and
Stroke, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
Date: April 30, 2024.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators. The
agenda will include an overview of the
National Center for Complementary and
Integrative Health (NCCIH) program.
Place: Porter Neuroscience Research
Center, Building 35A, 35 Convent Drive,
Bethesda, MD 20892 (Virtual Meeting).
Date: May 6–7, 2024.
Time: May 6, 2024, 9:00 a.m. to 8:00 p.m.
May 7, 2024, 9:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators. The
agenda will include review of an investigator
in the National Center for Complementary
and Integrative Health (NCCIH) program.
Place: Porter Neuroscience Research
Center, Building 35A, 35 Convent Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jeffrey S. Diamond, Ph.D.,
Scientific Director, c/o Caren Collins,
National Institute of Neurological Disorders
and Stroke, NIH, Building 35, Room GF–149,
Bethesda, MD 20892, 301–435–1896,
diamondj@ninds.nih.gov; collinsca@
ninds.nih.gov.
Name of Committee: Board of Scientific
Counselors, National Institute of
Neurological Disorders and Stroke.
Date: June 14, 2024.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: Porter Neuroscience Research
Center, Building 35A, 35 Convent Drive,
Bethesda, MD 20892 (Virtual Meeting).
VerDate Sep<11>2014
16:49 Mar 28, 2024
Jkt 262001
Date: June 24–25, 2024.
Time: June 24, 2024, 8:30 a.m. to 9:00 p.m.
June 25, 2024, 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: Neuroscience Center, 6001
Executive Boulevard Bethesda, MD 20892
(Hybrid Meeting).
Contact Person: Jeffrey S. Diamond, Ph.D.,
Scientific Director, c/o Caren Collins,
National Institute of Neurological Disorders
and Stroke, NIH, Building 35, Room GF–149,
Bethesda, MD 20892, 301–435–1896,
diamondj@ninds.nih.gov; collinsca@
ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS.)
Dated: March 26, 2024
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–06698 Filed 3–28–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Integrative Vascular Biology and
Hematology Coagulation.
Date: April 26, 2024.
Time: 9:00 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dmitri V. Gnatenko, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, gnatenkod2@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 26, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–06696 Filed 3–28–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Time-Sensitive
Obesity Policy Review.
Date: April 25, 2024.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
Division of Extramural Activities, NIDDK,
National Institutes of Health, Room 7353,
6707 Democracy Boulevard, Bethesda, MD
20892–2542, (301) 594–8898, barnardm@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: March 25, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–06663 Filed 3–28–24; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\29MRN1.SGM
29MRN1
]]>Agencies
[Federal Register Volume 89, Number 62 (Friday, March 29, 2024)]
[Notices]
[Page 22166]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-06698]
[[Page 22166]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice
of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of meetings of the Board of Scientific
Counselors, National Institute of Neurological Disorders and Stroke.
The meetings will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute of Neurological Disorders and Stroke, including consideration
of personnel qualifications and performance, and the competence of
individual investigators, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Institute of Neurological Disorders and Stroke.
Date: April 30, 2024.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators. The agenda
will include an overview of the National Center for Complementary
and Integrative Health (NCCIH) program.
Place: Porter Neuroscience Research Center, Building 35A, 35
Convent Drive, Bethesda, MD 20892 (Virtual Meeting).
Date: May 6-7, 2024.
Time: May 6, 2024, 9:00 a.m. to 8:00 p.m. May 7, 2024, 9:30 a.m.
to 1:00 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators. The agenda
will include review of an investigator in the National Center for
Complementary and Integrative Health (NCCIH) program.
Place: Porter Neuroscience Research Center, Building 35A, 35
Convent Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jeffrey S. Diamond, Ph.D., Scientific Director,
c/o Caren Collins, National Institute of Neurological Disorders and
Stroke, NIH, Building 35, Room GF-149, Bethesda, MD 20892, 301-435-
1896, [email protected]; [email protected].
Name of Committee: Board of Scientific Counselors, National
Institute of Neurological Disorders and Stroke.
Date: June 14, 2024.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: Porter Neuroscience Research Center, Building 35A, 35
Convent Drive, Bethesda, MD 20892 (Virtual Meeting).
Date: June 24-25, 2024.
Time: June 24, 2024, 8:30 a.m. to 9:00 p.m. June 25, 2024, 10:00
a.m. to 1:00 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: Neuroscience Center, 6001 Executive Boulevard Bethesda,
MD 20892 (Hybrid Meeting).
Contact Person: Jeffrey S. Diamond, Ph.D., Scientific Director,
c/o Caren Collins, National Institute of Neurological Disorders and
Stroke, NIH, Building 35, Room GF-149, Bethesda, MD 20892, 301-435-
1896, [email protected]; [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.853,
Clinical Research Related to Neurological Disorders; 93.854,
Biological Basis Research in the Neurosciences, National Institutes
of Health, HHS.)
Dated: March 26, 2024
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-06698 Filed 3-28-24; 8:45 am]
BILLING CODE 4140-01-P
